Mandate

Vinge advises J.P. Morgan, Nordea and SEB Enskilda in connection with SAS rights issue

February 09, 2010

Vinge is advising J.P Morgan, Nordea and SEB Enskilda in connection with SAS AB’s new issue of ordinary shares for approximately SEK 5 billion with pre-emption rights for the company’s existing shareholders. J.P. Morgan, Nordea and SEB Enskilda which are acting as Joint Global Co-ordinators, Joint Lead Managers and Joint Bookrunners in the rights issue have, together with DnB NOR Markets, the Royal Bank of Scotland and Danske Markets, confirmed their willingness, subject to certain conditions, to severally enter into underwriting agreements in respect of 42.4 per cent of the shares in the issue.

SAS AB is listed on NASDAQ OMX Stockholm, NASDAQ OMX Copenhagen and Oslo Børs.

Vinge’s team primarily consisted of partners Göran Nyström, Rikard Stenberg and Lennart Larsson together with associates Johan Thiman, Johan Norström and Mårten Svensson.

Related

Vinge has advised Oncopeptides in connection with its rights issue

Vinge has advised Oncopeptides AB (publ) in connection with a fully guaranteed rights issue which will provide Oncopeptides with proceeds of approximately SEK 150 million before deduction of transaction costs.
August 28, 2025

Vinge advises Main Capital and Unik in connection with the acquisition of LEB System Aktiebolag

Vinge has advised Unik International ApS (“Unik”), a Danish Housing and Property Management software provider, in connection with the acquisition of LEB System Aktiebolag. The synergistic acquisition is expected to complement and expand Unik’s offering and has a strong strategic fit with Unik and is in line with the company’s internationalization strategy in the Nordic Property Management software market.
August 28, 2025

Vinge has advised Xspray Pharma in connection with its rights issue and debt refinancing

Vinge has advised Xspray Pharma AB (publ) in connection with a rights issue of approximately SEK 130 million before transaction costs, with an over-allotment issue of approximately SEK 20 million, and refinancing of an existing loan.
August 28, 2025